3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Signs and Symptoms
1
Psoriasis
1
Nutrition Disorders
1
Insulin Resistance
1
Inflammatory Bowel Diseases
1
Glioma
1
Glioblastoma
1
Gastroparesis
1
Feeding and Eating Disorders
1
Esophageal Neoplasms
1
Dumping Syndrome
1
Diarrhea
1
Breast Neoplasms
1
Brain Neoplasms
1
Arthritis, Rheumatoid
1
Interventions
Metformin
18
Inositol
5
Exercise
4
Pioglitazone
3
Insulin
3
Ethinyl Estradiol
3
drospirenone and ethinyl estradiol combination
2
Surveys and Questionnaires
2
Cyproterone Acetate
2
Acupuncture Therapy
2
ziprasidone
1
salicylsalicylic acid
1
maltodextrin
1
licogliflozin
1
exendin (9-39)
1
drospirenone
1
cinnulin PF
1
Zoledronic Acid
1
Waist-Hip Ratio
1
Waist Circumference
1
Vitamin D
1
Time
1
Thioctic Acid
1
Tablets
1
Sulfasalazine
1
Sugars
1
Sodium-Glucose Transporter 2 Inhibitors
1
Sodium Salicylate
1
Saline Solution
1
Resistance Training
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Insulin Resistance
×
Sulfasalazine
×
Clear all
NCT03734627
2021-08-16
EndoGut
St. James's Hospital, Ireland
Completed
40 enrolled